FDA Transparency and Oversight, Investor Panel
A forum on transparency at the Food and Drug Administration featured a discussion on how transparency can affect investo…
Dr. Gottleib explains a new initative by the FDA to allow greater access to clinical trial data.
A forum on transparency at the Food and Drug Administration featured a discussion on how transparency can affect investo…
Physicians and medical researchers talked about ways for the Food and Drug Administration to correct misinformation in t…
Commissioner Scott Gottlieb testified before a Senate Appropriations subcommittee on the President Trump’s fiscal year 2…
Scott Gottlieb talked about the nation’s opioid epidemic, as well as drug prices and the Food and Drug Administration’s …